OS Therapies (OSTX) Receivables - Other (2024 - 2025)

OS Therapies' (OSTX) quarterly Receivables - Other came in at $23636.0 in Q1 2025, down 69.5% on a QoQ basis from $77500.0 in Q3 2024.

OS Therapies (OSTX) Receivables - Other (2024 - 2025) Analysis & Trends

OS Therapies (OSTX) has 2 years of Receivables - Other data on file, last reported at $23636.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.84 Bn	131.99 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.48 Bn	78.49 Bn	3.93 Bn
3	Argenx Se	65.47 Bn	60.29 Bn	1.37 Bn
4	Moderna	60.15 Bn	55.01 Bn	52.00 Mn
5	BeOne Medicines	42.22 Bn	37.12 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.67 Bn	28.36 Bn	992.69 Mn
7	BioNTech SE	28.54 Bn	10.14 Bn	668.28 Mn
8	Insmed	27.58 Bn	26.42 Bn	358.27 Mn
9	Royalty Pharma	27.22 Bn	26.38 Bn	-
10	OS Therapies	19.85 Mn	19.85 Mn	-

Download Data